Results 221 to 230 of about 1,543,966 (410)

Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Adropin is related to the energy homeostasis‐associated gene. It significantly increased glutathione reductase enzyme levels in the pancreas of experimental diabetic rats. Adropin may reduce the severity of diabetes and its complications. Cell proliferation in the exocrine is reduced after the administration of adropin.
Ifrah I. Ali   +4 more
wiley   +1 more source

Advancing the Prediction and Understanding of Placebo Responses in Chronic Back Pain Using Large Language Models. [PDF]

open access: yesEur J Pain
Nunes DAP   +8 more
europepmc   +1 more source

Chlorpromazine versus placebo for schizophrenia [PDF]

open access: yes, 2014
Abrams   +486 more
core   +1 more source

Exogenous Surfactant Versus Placebo in the Treatment of Moderate and Severe ARDS in COVID-19: The Pilot Study of a Clinical Trial [PDF]

open access: gold, 2020
Mehdi Ghahremani   +13 more
openalex   +1 more source

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

open access: yesNew England Journal of Medicine, 2016
F. Nevens   +31 more
semanticscholar   +1 more source

Pimobendan alleviates myocyte apoptosis and fibrosis associated with mitral regurgitation by targeting endoplasmic reticulum stress

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Mitral regurgitation (MR) causes volume overload and disrupts Ca2+ homeostasis. The volume overload leads to cardiac hypertrophy and fibrosis inferred from histopathological studies. Cardiac hypertrophy was identified by increased myocyte cross‐sectional area, left atrial‐to‐aortic root ratio, and left ventricular internal diameter at end‐diastole ...
Pakit Boonpala   +10 more
wiley   +1 more source

On blaming the placebo [PDF]

open access: yesArthritis & Rheumatism, 1991
W V, Epstein, C J, Henke
openaire   +2 more sources

Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial [PDF]

open access: hybrid
Christopher Farina   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy